Concepedia

Lukas Donix

LD

Statistics

Publications

3

Citations

52

H-Index

3

Active since

2017

Affiliations

Technische Universität Dresden(Current)

National Center for Tumor Diseases

Nationales Centrum für Tumorerkrankungen Dresden

University Hospital Carl Gustav Carus

Lukas Donix is an author at Technische Universität Dresden specializing in pharmacology, molecular oncology, and cancer pharmacology.

Publications per year

2017–2022

3

Publications

3

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

Holger H.H. Erb, Julia Bodenbender, Florian Handle et al. · PLoS ONE · 2020 · 20 citations · Full text

, , +17

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

Dinah Linke, Lukas Donix, Claudia Peitzsch et al. · International Journal of Molecular Sciences · 2022 · 19 citations · Full text

, , +17

Mast cells increase adult neural precursor proliferation and differentiation but this potential is not realized in vivo under physiological conditions

Joanna M. Wasielewska, Lisa Grönnert, Nicole Rund et al. · Scientific Reports · 2017 · 13 citations · Full text

, , +17

1–3 of 3